Lbp Am Sa Buys 15,965 Shares of STERIS plc (NYSE:STE)

LBP AM SA boosted its position in STERIS plc (NYSE:STE - Free Report) by 151.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,519 shares of the medical equipment provider's stock after buying an additional 15,965 shares during the period. LBP AM SA's holdings in STERIS were worth $5,451,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Ashton Thomas Securities LLC acquired a new position in STERIS in the third quarter valued at $25,000. Human Investing LLC acquired a new position in STERIS in the fourth quarter valued at $31,000. Anfield Capital Management LLC lifted its holdings in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division lifted its holdings in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC lifted its holdings in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on STE shares. JMP Securities reiterated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Stephens reiterated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, STERIS has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

Remove Ads

STERIS Stock Up 0.2 %

Shares of NYSE STE traded up $0.48 during trading on Tuesday, hitting $228.29. 454,011 shares of the company traded hands, compared to its average volume of 500,878. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The business's fifty day moving average is $220.09 and its 200 day moving average is $222.22. The firm has a market capitalization of $22.43 billion, a price-to-earnings ratio of 48.47 and a beta of 0.92. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS's payout ratio is 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.